These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

118 related articles for article (PubMed ID: 8846997)

  • 1. Protective effects of glucose-6-phosphate and NADP against alpha-chaconine-induced developmental toxicity in Xenopus embryos.
    Rayburn JR; Bantle JA; Qualls CW; Friedman M
    Food Chem Toxicol; 1995 Dec; 33(12):1021-5. PubMed ID: 8846997
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Synergistic interaction of glycoalkaloids alpha-chaconine and alpha-solanine on developmental toxicity in Xenopus embryos.
    Rayburn JR; Friedman M; Bantle JA
    Food Chem Toxicol; 1995 Dec; 33(12):1013-9. PubMed ID: 8846996
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Developmental toxicology of potato alkaloids in the frog embryo teratogenesis assay--Xenopus (FETAX).
    Friedman M; Rayburn JR; Bantle JA
    Food Chem Toxicol; 1991 Aug; 29(8):537-47. PubMed ID: 1894220
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Amelioration by glucose-6-phosphate and NADP of potato glycoalkaloid inhibition in cell, enzyme and liposome assays.
    Roddick JG; Leonard AL
    Phytochemistry; 1999 May; 51(1):23-7. PubMed ID: 10349728
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Evaluation of the developmental toxicity of thalidomide using frog embryo teratogenesis assay-xenopus (FETAX): biotransformation and detoxification.
    Fort DJ; Stover EL; Bantle JA; Finch RA
    Teratog Carcinog Mutagen; 2000; 20(1):35-47. PubMed ID: 10607376
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Evaluation of the developmental toxicity of caffeine and caffeine metabolites using the frog embryo teratogenesis assay--Xenopus (FETAX).
    Fort DJ; Stover EL; Propst TL; Faulkner BC; Vollmuth TA; Murray FJ
    Food Chem Toxicol; 1998 Jul; 36(7):591-600. PubMed ID: 9687966
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Analysis of the mechanism of isoniazid-induced developmental toxicity with frog embryo teratogenesis assay: Xenopus (FETAX).
    Fort DJ; Bantle JA
    Teratog Carcinog Mutagen; 1990; 10(6):463-76. PubMed ID: 1982910
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Phase III interlaboratory study of FETAX. Part 3. FETAX validation using 12 compounds with and without an exogenous metabolic activation system.
    Bantle JA; Finch RA; Fort DJ; Stover EL; Hull M; Kumsher-King M; Gaudet-Hull AM
    J Appl Toxicol; 1999; 19(6):447-72. PubMed ID: 10547627
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The folic acid analogue methotrexate protects frog embryo cell membranes against damage by the potato glycoalkaloid alpha-chaconine.
    McWilliams ML; Blankemeyer JT; Friedman M
    Food Chem Toxicol; 2000 Oct; 38(10):853-9. PubMed ID: 11039318
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Development of a metabolic activation system for the frog embryo teratogenesis assay: Xenopus (FETAX).
    Fort DJ; Dawson DA; Bantle JA
    Teratog Carcinog Mutagen; 1988; 8(5):251-63. PubMed ID: 2905834
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Evaluation of the developmental toxicity of five compounds with the frog embryo teratogenesis assay: Xenopus (FETAX) and a metabolic activation system.
    Fort DJ; James BL; Bantle JA
    J Appl Toxicol; 1989 Dec; 9(6):377-88. PubMed ID: 2613998
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Evaluation of the developmental toxicities of ethanol, acetaldehyde, and thioacetamide using FETAX.
    Fort DJ; McLaughlin DW; Rogers RL; Buzzard BO
    Drug Chem Toxicol; 2003 Feb; 26(1):23-34. PubMed ID: 12643038
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Optimization of an exogenous metabolic activation system for FETAX. I. Post-isolation rat liver microsome mixtures.
    Fort DJ; Rogers RL; Stover EL; Finch RA
    Drug Chem Toxicol; 2001 May; 24(2):103-15. PubMed ID: 11360429
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Phase III interlaboratory study of FETAX, Part 2: interlaboratory validation of an exogenous metabolic activation system for frog embryo teratogenesis assay--Xenopus (FETAX).
    Fort DJ; Stover EL; Bantle JA; Rayburn JR; Hull MA; Finch RA; Burton DT; Turley SD; Dawson DA; Linder G; Buchwalter D; Dumont JN; Kumsher-King M; Gaudet-Hull AM
    Drug Chem Toxicol; 1998 Feb; 21(1):1-14. PubMed ID: 9530526
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Evaluation of the developmental toxicity of 4-bromobenzene using frog embryo teratogenesis assay--Xenopus: possible mechanisms of action.
    Fort DJ; Propst TL; Stover EL
    Teratog Carcinog Mutagen; 1996; 16(6):307-15. PubMed ID: 9178453
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Assessing the predictive validity of frog embryo teratogenesis assay-Xenopus (FETAX).
    Fort DJ; Stover EL; Farmer DR; Lemen JK
    Teratog Carcinog Mutagen; 2000; 20(2):87-98. PubMed ID: 10679752
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Evaluation of Xenopus tropicalis as an alternative test organism for frog embryo teratogenesis assay--Xenopus (FETAX).
    Song MO; Fort DJ; McLaughlin DL; Rogers RL; Thomas JH; Buzzard BO; Noll AM; Myers NK
    Drug Chem Toxicol; 2003 Aug; 26(3):177-89. PubMed ID: 12953658
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The use of in vitro fertilization in the Frog Embryo Teratogenesis Assay in Xenopus (FETAX) and its applications to ecotoxicology.
    Vismara C; Bernardini G; Bonfanti P; Colombo A; Camatini M
    Sci Total Environ; 1993; Suppl Pt 1():787-90. PubMed ID: 8108713
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Optimization of an exogenous metabolic activation system for FETAX. II. Preliminary evaluation.
    Fort DJ; Rogers RL; Paul RR; Stover EL; Finch RA
    Drug Chem Toxicol; 2001 May; 24(2):117-27. PubMed ID: 11360430
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Studies of an S9-based metabolic activation system used in the mouse lymphoma L5178Y cell mutation assay.
    McGregor DB; Edwards I; Riach CG; Cattanach P; Martin R; Mitchell A; Caspary WJ
    Mutagenesis; 1988 Nov; 3(6):485-90. PubMed ID: 3070287
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.